Poster: CML-047 Post Hoc Analysis of Responses to Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) by Baseline BCR::ABL1 Level and Baseline Mutation Status in the OPTIC Trial
Year: 2022
Type: article
Authors: Michael Deininger, Jane Apperley, Christopher Kevin Arthur, Charles Chuah, Andreas Hochhaus, Hugues de Lavallade, Jeffrey Lipton, Elza Lomaia, James McCloskey, Lori Maness, Michael Mauro, Beatriz Moraghi, Carolina Pavlovsky, Gianantonio Rosti, Philippe Rousselot, Maria Undurraga Sutton, Xiaowei Ren, Alexander Vorog, Jorge Cortes
Institution: Versiti Blood Research Institute Foundation
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4296533946